<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Wed, 22 Apr 2026 21:22:32 -0400--><rss version="2.0">
    <channel>
        <title>Corbus Pharmaceuticals Holdings, Inc. (CRBP) SEC Filings</title>
        <link>https://ir.corbuspharma.com/sec-filings/quarterly-reports/rss</link>
        <description>Corbus Pharmaceuticals Holdings, Inc. (CRBP) - Quarterly Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_dc5231ac157b9ee4fb322b64fcb7a082/corbuspharma/files/theme/images/logo-sm.png</url>
                <title>Corbus Pharmaceuticals Holdings, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-25-277748/0001193125-25-277748.pdf</link>
                <pubDate>Wed, 12 Nov 25 00:00:00 -0500</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-25-277748/0001193125-25-277748.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-25-103118/0000950170-25-103118.pdf</link>
                <pubDate>Tue, 05 Aug 25 00:00:00 -0400</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-25-103118/0000950170-25-103118.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-25-064507/0000950170-25-064507.pdf</link>
                <pubDate>Tue, 06 May 25 00:00:00 -0400</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-25-064507/0000950170-25-064507.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-24-123486/0000950170-24-123486.pdf</link>
                <pubDate>Thu, 07 Nov 24 00:00:00 -0500</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-24-123486/0000950170-24-123486.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-24-091922/0000950170-24-091922.pdf</link>
                <pubDate>Tue, 06 Aug 24 00:00:00 -0400</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-24-091922/0000950170-24-091922.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-24-054625/0000950170-24-054625.pdf</link>
                <pubDate>Tue, 07 May 24 00:00:00 -0400</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-24-054625/0000950170-24-054625.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-23-060377/0000950170-23-060377.pdf</link>
                <pubDate>Tue, 07 Nov 23 00:00:00 -0500</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-23-060377/0000950170-23-060377.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-23-039960/0000950170-23-039960.pdf</link>
                <pubDate>Tue, 08 Aug 23 00:00:00 -0400</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-23-039960/0000950170-23-039960.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31, EX-31, EX-32, EX-32]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-23-019825/0000950170-23-019825.pdf</link>
                <pubDate>Tue, 09 May 23 00:00:00 -0400</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-23-019825/0000950170-23-019825.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-22-023282/0000950170-22-023282.pdf</link>
                <pubDate>Tue, 08 Nov 22 00:00:00 -0500</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000950170-22-023282/0000950170-22-023282.pdf</guid>
                                                                            </item>
            </channel>
</rss>